Scholz London buys out Herman Beasley

LONDON - Scholz & Friends has nearly doubled its London billings by acquiring one of the UK's largest independent healthcare agencies, Herman Beasley.

Herman Beasley, which rose to fame as the first UK agency to advertise the symptoms of a condition rather than the drug itself, will swell Scholz's billings from £11 million to £19 million. The move will cement Scholz London's position as the company's biggest agency outside its home base of Germany.

Now styled as a "life sciences" rather than a healthcare agency, its client list spans drugs companies, veterinary services, garden products and so-called functional foods, the relatively new category of foods that claim to offer health benefits such as lowering cholesterol levels.

Herman Beasley's 20 staff will work from Scholz's offices in Clerkenwell, London.

"We won network business in healthcare from Schering and so Scholz wanted to acquire some expertise in the area," Kate Robertson, the chief executive of Scholz in London, said.

"I didn't just want to purchase turnover. I wanted to get some more good management for the agency. Life sciences is a fast-growing area and the fit with Herman Beasley's client list was very good."